Research areas

Establishing ambulatory management pathways, evaluating predictive biomarkers, and running pragmatic clinical trials comparing intervention strategies such as pleural aspiration versus chest tube insertion.

Personalising treatments, minimising drug side effects, and reducing hospital readmissions and cardiovascular complications.

Tracking hospitalised patient outcomes through the DISCOVER study, evaluating the psychological impact and lived experiences of long-COVID in the PELCO study, measuring procedural aerosol emissions in the AERATOR project to prove that a patient's cough poses a greater transmission risk than most medical devices, and evaluating potential treatments through national platform trials such as RECOVERY.